Sun Pharmaceutical Industries Ltd. closed 11.02% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

After a consistent five-day rally, the market may consolidate, though the overall trend remains positive. Below are some ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

The stock market is showing signs of strength again, delighting investors. Analysts have selected 10 amazing stocks for ...

Branded generics may still dominate volumes, but the real value lies in consumer health. As margin pressures grow, Indian ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

Sun Pharmaceutical Industries Ltd. 524715 shares rallied 1.04% to 1,705.15 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE SENSEX ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

US President Donald Trump has stated that the country is set to announce “major tariffs” on pharmaceutical imports very soon.

The pharma sector is likely to maintain steady earnings. Most brokerages flag US business recovery as the key swing factor ...